Nuvectis Pharma, Inc.

NVCTNASDAQHealthcare● Active

$9.66

+$0.24(+2.49%)

Market Cap$256104021

P/E Ratio—

52W High$13.34

52W Low$5.55

Avg Volume80K

Open$9.52

Beta-0.07

Overview

Nuvectis Pharma, Inc. (NVCT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · NVCT · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Nuvectis Pharma, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

NVCT insider buying and selling by quarter

NVCT insider selling · NVCT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

841K421K0

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · NVCT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

NVCT executive sell shares · NVCT board member insider trading · NVCT insider trading SEC filing

Showing 89 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jan 6, 2026	Shemesh Shay Chief Dev. & Ops. Officer	Award	150,000	—	—	1,793,068	Form 4
Jan 6, 2026	BENTSUR RON Chairman & CEO · Director	Award	150,000	—	—	3,675,924	Form 4
Jan 6, 2026	Poradosu Enrique Chief Science & Business Off	Award	150,000	—	—	1,806,319	Form 4
Jan 6, 2026	Carson Michael J. Vice President, Finance	Award	61,200	—	—	200,118	Form 4
Nov 5, 2025	BENTSUR RON Chairman & CEO · Director	Purchase	5,000	$5.72	$29K	3,525,924	Form 4
Nov 5, 2025	Sanchez Juan Director	Purchase	13,000	$5.79	$75K	78,150	Form 4
Nov 5, 2025	Kaplan Matthew L. Director	Purchase	11,000	$5.84	$64K	124,760	Form 4
Sep 22, 2025	Sanchez Juan Director	Award	30,000	—	—	65,150	Form 4
Oct 27, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	72,836	$6.28	$457K	3,136,576	Form 4
Oct 24, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	35,034	$6.15	$215K	3,063,740	Form 4
Oct 23, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	46,900	$6.06	$284K	3,028,706	Form 4
Jun 20, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	5,603	$7.99	$45K	2,981,806	Form 4
Jun 18, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	28,043	$8.05	$226K	2,976,203	Form 4
Jun 17, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	5,399	$8.11	$44K	2,948,160	Form 4
Jun 12, 2025	Kaplan Matthew L. Director	Award	30,000	—	—	113,760	Form 4
Jun 12, 2025	Oliviero James F III Director	Award	30,000	—	—	87,828	Form 4
Jun 12, 2025	Hoberman Kenneth Director	Award	30,000	—	—	133,140	Form 4
May 12, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	21,167	$8.11	$172K	2,942,761	Form 4
May 8, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	2,400	$8.65	$21K	2,911,532	Form 4
May 8, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	100	$8.65	$865	2,909,132	Form 4
May 8, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	100	$8.65	$865	2,909,032	Form 4
May 8, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	50	$8.65	$433	2,908,932	Form 4
May 7, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	9,614	$8.64	$83K	2,908,882	Form 4
May 7, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	2,703	$8.40	$23K	2,899,268	Form 4
May 6, 2025	Mosseri Marlio Charles 10 percent owner	Purchase	10,104	$8.64	$87K	2,896,565	Form 4

Shemesh Shay

Chief Dev. & Ops. Officer

Award

Date

Jan 6

150,000

Price

—

Value

—

View Form 4 on SEC.gov

BENTSUR RON

Chairman & CEO · Director

Award

Date

Jan 6

150,000

Price

—

Value

—

View Form 4 on SEC.gov

Poradosu Enrique

Chief Science & Business Off

Award

Date

Jan 6

150,000

Price

—

Value

—

View Form 4 on SEC.gov

Carson Michael J.

Vice President, Finance

Award

Date

Jan 6

61,200

Price

—

Value

—

View Form 4 on SEC.gov

BENTSUR RON

Chairman & CEO · Director

Purchase

Date

Nov 5

5,000

Price

$5.72

Value

$29K

View Form 4 on SEC.gov

Sanchez Juan

Director

Purchase

Date

Nov 5

13,000

Price

$5.79

Value

$75K

View Form 4 on SEC.gov

Kaplan Matthew L.

Director

Purchase

Date

Nov 5

11,000

Price

$5.84

Value

$64K

View Form 4 on SEC.gov

Sanchez Juan

Director

Award

Date

Sep 22

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Oct 27

72,836

Price

$6.28

Value

$457K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Oct 24

35,034

Price

$6.15

Value

$215K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Oct 23

46,900

Price

$6.06

Value

$284K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Jun 20

5,603

Price

$7.99

Value

$45K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Jun 18

28,043

Price

$8.05

Value

$226K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

Jun 17

5,399

Price

$8.11

Value

$44K

View Form 4 on SEC.gov

Kaplan Matthew L.

Director

Award

Date

Jun 12

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Oliviero James F III

Director

Award

Date

Jun 12

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Hoberman Kenneth

Director

Award

Date

Jun 12

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 12

21,167

Price

$8.11

Value

$172K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 8

2,400

Price

$8.65

Value

$21K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 8

100

Price

$8.65

Value

$865

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 8

100

Price

$8.65

Value

$865

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 8

Price

$8.65

Value

$433

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 7

9,614

Price

$8.64

Value

$83K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 7

2,703

Price

$8.40

Value

$23K

View Form 4 on SEC.gov

Mosseri Marlio Charles

10 percent owner

Purchase

Date

May 6

10,104

Price

$8.64

Value

$87K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About NVCT insider trading

NVCT insider trades

Nuvectis Pharma, Inc. (NVCT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Mosseri Marlio Charles (10 percent owner), BENTSUR RON (Chairman & CEO · Director), Sanchez Juan (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. NVCT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Nuvectis Pharma, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

NVCT insider trading · 5 questions

The insiders of Nuvectis Pharma, Inc. (NVCT) include executives and directors such as Mosseri Marlio Charles (10 percent owner), BENTSUR RON (Chairman & CEO · Director), Sanchez Juan (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

NVCT board member insider tradingwho are NVCT insidersNVCT insider rosterNuvectis Pharma, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026